[go: up one dir, main page]

AU2001294617A1 - Method of inducing apoptosis in lymphoid cells - Google Patents

Method of inducing apoptosis in lymphoid cells

Info

Publication number
AU2001294617A1
AU2001294617A1 AU2001294617A AU9461701A AU2001294617A1 AU 2001294617 A1 AU2001294617 A1 AU 2001294617A1 AU 2001294617 A AU2001294617 A AU 2001294617A AU 9461701 A AU9461701 A AU 9461701A AU 2001294617 A1 AU2001294617 A1 AU 2001294617A1
Authority
AU
Australia
Prior art keywords
inducing apoptosis
lymphoid cells
lymphoid
apoptosis
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294617A
Inventor
Laxminarayana Devireddy
Michael R Green
Fabian Richard
Jose G. Teodoro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts Amherst
Original Assignee
University of Massachusetts Amherst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts Amherst filed Critical University of Massachusetts Amherst
Publication of AU2001294617A1 publication Critical patent/AU2001294617A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001294617A 2000-09-21 2001-09-21 Method of inducing apoptosis in lymphoid cells Abandoned AU2001294617A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23421600P 2000-09-21 2000-09-21
US60/234,216 2000-09-21
PCT/US2001/029513 WO2002024866A2 (en) 2000-09-21 2001-09-21 Method of inducing apoptosis in lymphoid cells

Publications (1)

Publication Number Publication Date
AU2001294617A1 true AU2001294617A1 (en) 2002-04-02

Family

ID=22880428

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294617A Abandoned AU2001294617A1 (en) 2000-09-21 2001-09-21 Method of inducing apoptosis in lymphoid cells

Country Status (3)

Country Link
US (2) US7235520B2 (en)
AU (1) AU2001294617A1 (en)
WO (1) WO2002024866A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10230631A1 (en) * 2002-07-02 2004-01-22 Metagen Pharmaceuticals Gmbh Uses of Ngal-binding substances for the diagnosis and treatment of cancer
AU2003247303A1 (en) * 2002-07-17 2004-02-02 Index Pharmaceuticals Ab Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders
US7056702B2 (en) * 2002-12-16 2006-06-06 Kimberly Clark Co Detecting lipocalin
WO2005052125A2 (en) * 2003-11-21 2005-06-09 University Of Massachusetts 24p3 receptors and uses thereof
WO2006078717A2 (en) * 2005-01-19 2006-07-27 Beth Israel Deaconess Medical Center Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
US20080274104A1 (en) * 2005-02-10 2008-11-06 Arlinghaus Ralph B Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics
KR100681763B1 (en) * 2005-02-28 2007-02-15 재단법인 목암생명공학연구소 Cancer metastasis inhibiting pharmaceutical composition comprising human lipocalin 2 as an active ingredient, cancer metastasis inhibiting method using same
US7997629B2 (en) 2008-09-12 2011-08-16 Dr. Slick Company Knot tying apparatus
JP2013529907A (en) 2010-05-24 2013-07-25 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク NGAL protein variants and uses thereof
DK2640740T3 (en) * 2010-11-15 2017-06-26 Pieris Pharmaceuticals Gmbh MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3)
WO2014081980A2 (en) 2012-11-21 2014-05-30 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof
BR112017020445A2 (en) 2015-05-18 2018-07-03 Pieris Pharmaceuticals Gmbh fusion polypeptide, nucleic acid molecule, host cell, method of producing a fusion polypeptide, use of fusion polypeptide, method for activating signaling pathways, method for co-stimulating cells, method for inducing lymphocyte proliferation, and method for direct cd137 collation
CA2982034A1 (en) 2015-05-18 2016-11-24 Pieris Pharmaceuticals Gmbh Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277565B1 (en) * 1997-11-06 2001-08-21 Millennium Pharmaceuticals, Inc. OCT-3 gene encoding transporter-like molecules
WO2005052125A2 (en) * 2003-11-21 2005-06-09 University Of Massachusetts 24p3 receptors and uses thereof
US20080274104A1 (en) * 2005-02-10 2008-11-06 Arlinghaus Ralph B Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics

Also Published As

Publication number Publication date
US20020128194A1 (en) 2002-09-12
WO2002024866A3 (en) 2002-10-03
US7235520B2 (en) 2007-06-26
WO2002024866A2 (en) 2002-03-28
US20080249010A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
AU2001245928A1 (en) Electrolyzer and method of using the same
AU7886301A (en) Transesterification process
AU3867400A (en) Methods of using bioelastomers
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU6084900A (en) Novel materials and methods for water purification
AU2002216966A1 (en) Sludge inerting method
AU2001294617A1 (en) Method of inducing apoptosis in lymphoid cells
EP1321763A4 (en) Enzyme electrode
AUPR074500A0 (en) Treatment of t cell disorders
AU2001227972A1 (en) Methods to treat alpha-1-antitrypsin deficiency
AU2001256555A1 (en) New inhibotor of apoptosis of nerve cells
AU2001294258A1 (en) Method of purifying plavastatin
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001236718A1 (en) Bioreactor and related method
AUPQ989400A0 (en) Water treatment apparatus
AU3423701A (en) Arrangement and method for cleaning fronts
AU2002359322A1 (en) Method of inducing apoptosis in hyperproliferative cells
AU2001277247A1 (en) Electrophoresis apparatus and method
AU2001248758A1 (en) Burning method utilizing water
AU2002216258A1 (en) Method and means for pre-heating water
AUPR172900A0 (en) Water purification apparatus
AU2002214048A1 (en) Process for increasing the level of sterols in plants
AU2000277668A1 (en) Cooling of ballast in water purification apparatus
AU6056400A (en) Method of inducing apoptosis in b-lymphocytes
AU2002344717A1 (en) Method of inducing apoptosis in cancer cells